CRP and myelodysplastic syndrome: While this was not defined explicitly, it was evaluated as being the same as “transplantation-related mortality.” Among patients with MDS who underwent HSCT, continuous SF in units of 1000 ng/mL was assessed as a potential prognostic factor for NRM; in the multivariate analysis (controlling for age, sex, transfusions, comorbidities, C-reactive protein levels, WHO classification, and conditioning regimen at HSCT), there was no significant relationship between increase in SF levels and the risk of NRM (HR: 1.1; 95% CI: 0.8–1.4; p = 0.06) [17].